Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Depreciation and Depletion (2020 - 2025)

Vivos Therapeutics has reported Depreciation and Depletion over the past 6 years, most recently at -$200000.0 for Q4 2025.

  • Quarterly Depreciation and Depletion fell 300.0% to -$200000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $700000.0 through Dec 2025, up 75.0% year-over-year, with the annual reading at $700000.0 for FY2025, 40.0% up from the prior year.
  • Depreciation and Depletion was -$200000.0 for Q4 2025 at Vivos Therapeutics, down from $400000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $400000.0 in Q3 2025 and troughed at -$200000.0 in Q4 2025.
  • The 5-year median for Depreciation and Depletion is $100000.0 (2021), against an average of $149029.8.
  • Year-over-year, Depreciation and Depletion skyrocketed 800.67% in 2021 and then plummeted 300.0% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $100000.0 in 2021, then skyrocketed by 200.0% to $300000.0 in 2022, then tumbled by 33.33% to $200000.0 in 2023, then crashed by 50.0% to $100000.0 in 2024, then plummeted by 300.0% to -$200000.0 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Depreciation and Depletion are -$200000.0 (Q4 2025), $400000.0 (Q3 2025), and $300000.0 (Q2 2025).